TJ9 Stock Overview
Provides aesthetic and dermatology solutions for medical practitioners worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Cutera, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.29 |
| 52 Week High | US$4.40 |
| 52 Week Low | US$0.26 |
| Beta | 1.35 |
| 11 Month Change | -49.93% |
| 3 Month Change | -59.15% |
| 1 Year Change | -83.47% |
| 33 Year Change | -99.17% |
| 5 Year Change | -99.15% |
| Change since IPO | -96.03% |
Recent News & Updates
Recent updates
Shareholder Returns
| TJ9 | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | -1.8% | 0.5% | 0.2% |
| 1Y | -83.5% | -6.8% | 8.5% |
Return vs Industry: TJ9 underperformed the German Medical Equipment industry which returned -6.8% over the past year.
Return vs Market: TJ9 underperformed the German Market which returned 8.5% over the past year.
Price Volatility
| TJ9 volatility | |
|---|---|
| TJ9 Average Weekly Movement | 14.1% |
| Medical Equipment Industry Average Movement | 5.4% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.9% |
| 10% least volatile stocks in DE Market | 2.3% |
Stable Share Price: TJ9's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: TJ9's weekly volatility (14%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1998 | 430 | Taylor Harris | www.cutera.com |
Cutera, Inc. provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. The company provides AviClear for the treatment of mild, moderate, and severe inflammatory acne vulgaris; Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for skin revitalization; truFlex, a bio-electrical muscle stimulation device designs to strengthen, firm and tone the abdomen, buttocks, and thighs; and excel V/V+, a vascular and benign pigmented lesion treatment platform.
Cutera, Inc. Fundamentals Summary
| TJ9 fundamental statistics | |
|---|---|
| Market cap | €6.14m |
| Earnings (TTM) | -€138.00m |
| Revenue (TTM) | €149.05m |
0.0x
P/S Ratio0.0x
P/E RatioIs TJ9 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| TJ9 income statement (TTM) | |
|---|---|
| Revenue | US$155.21m |
| Cost of Revenue | US$146.01m |
| Gross Profit | US$9.20m |
| Other Expenses | US$152.91m |
| Earnings | -US$143.71m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -7.12 |
| Gross Margin | 5.93% |
| Net Profit Margin | -92.59% |
| Debt/Equity Ratio | -166.3% |
How did TJ9 perform over the long term?
See historical performance and comparison